NEO Stock Analysis: Buy, Sell, or Hold?
NEO - NeoGenomics, Inc.
$11.20
0.07 (0.63%)
▲
5d:
+0.45%
30d:
+25.84%
90d:
+40.7%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When NEO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NEO shows positive signals but monitor for confirmation. Market pricing in 9.8% decline. Moderate conviction.
💡 BUY OPPORTUNITY: NEO shows positive signals but monitor for confirmation. Market pricing in 9.8% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.75
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$11.02
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NEO is currently trading at $11.20, which is considered slightly high relative to its 30-day fair value range of $9.08 to $11.20. From a valuation perspective, the stock is trading at a discount (Forward PE: 30.7) compared to its historical average (41.8). Remarkably, the market is currently pricing in an annual earnings decline of 9.8% over the next few years. This pessimistic expectation contrasts with the company's recent 130.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, NEO is in a downtrend. Immediate support is located at $9.20, while resistance sits at $11.57.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.06 (+34.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NEO is in a downtrend. Immediate support is located at $9.20, while resistance sits at $11.57.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.06 (+34.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$9.08 -
$11.20
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.2%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 34.4% below Wall St target ($15.06)
Trading Range Analysis
30-Day Trading Range
$9.08 -
$11.20
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$9.20
Resistance Level
$11.58
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
30.72
Wall Street Target
$15.06
(+34.4%)
Revenue Growth (YoY)
11.1%
Earnings Growth (YoY)
130.6%
Profit Margin
-13.3%
Valuation Discount vs History
-9.8% cheaper
PE vs Historical
30.7 vs 41.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.8%
(market-implied from PE analysis)
1-Year Target
$10.10
(-10%)
2-Year Target
$9.11
(-19%)
3-Year Target
$8.22
(-27%)
3-Yr Target (if PE normalizes)
(PE: 31→42)
$11.18
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 30.7, Growth: 102.6%)
$37.80
(+238%)
Base:
(SPY PE: 21.8, Growth: 102.6%)
$26.80
(+139%)
Bear:
(PE: 18.5, Growth: 102.6%)
$22.78
(+103%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 30.7 to 41.8
Stabilization Target:
$15.24
(+36.1%)
PE Expansion Potential:
+36.1%
Share & Embed Analysis
Last updated: June 23, 2026 8:22 AM ET
Data refreshes hourly during market hours. Next update: 9:22 AM
Data refreshes hourly during market hours. Next update: 9:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Warren Stone
SELL
22128 shares
2026-01-20
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 56 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 51 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 62 BUY |
Advanced NEO Option Strategies
Professional options setups generated by AI based on today's NEO price and gamma walls.
